Badger Meter, Inc. (FRA:33B)
Germany · Delayed Price · Currency is EUR 161.40
-4.30 (-2.60%)
At close: Jul 29, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 135.74 | 124.94 | 92.6 | 66.5 | 60.88 | 49.34 | Upgrade |
Depreciation & Amortization | 33.16 | 32.19 | 28.11 | 26.24 | 27.86 | 25.22 | Upgrade |
Stock-Based Compensation | 7.31 | 6.18 | 5.19 | 3.15 | 2.33 | 1.42 | Upgrade |
Other Operating Activities | -11.2 | -11.23 | -9.99 | -6.27 | -3.29 | -2.88 | Upgrade |
Change in Accounts Receivable | -3.53 | -1.44 | -6.35 | -11.33 | -1.24 | 3.04 | Upgrade |
Change in Inventory | 21.6 | 10.32 | -32.47 | -21.02 | -13.63 | 5.13 | Upgrade |
Change in Accounts Payable | -9.28 | -12.16 | 8.51 | 28.01 | 7.01 | -0.39 | Upgrade |
Change in Other Net Operating Assets | 0.98 | 6.24 | 24.52 | -2.83 | 7.59 | 8.71 | Upgrade |
Operating Cash Flow | 174.77 | 155.03 | 110.12 | 82.45 | 87.51 | 89.58 | Upgrade |
Operating Cash Flow Growth | 37.34% | 40.79% | 33.55% | -5.78% | -2.31% | 10.98% | Upgrade |
Capital Expenditures | -14.71 | -12.82 | -12 | -5.89 | -6.75 | -9.06 | Upgrade |
Cash Acquisitions | -184.02 | -3 | -17.13 | - | -45.27 | -29.13 | Upgrade |
Other Investing Activities | - | - | - | - | 0.6 | - | Upgrade |
Investing Cash Flow | -198.73 | -15.82 | -29.13 | -5.89 | -51.42 | -38.19 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -4.6 | Upgrade |
Total Debt Repaid | - | - | - | - | - | -4.6 | Upgrade |
Net Debt Issued (Repaid) | - | - | - | - | - | -4.6 | Upgrade |
Issuance of Common Stock | 0.55 | 0.75 | 0.97 | 0.7 | 2.11 | 1.24 | Upgrade |
Repurchase of Common Stock | - | - | - | -0.43 | -0.46 | -3.12 | Upgrade |
Common Dividends Paid | -39.99 | -35.85 | -29.05 | -24.88 | -22.16 | -20.34 | Upgrade |
Other Financing Activities | - | - | - | - | - | -1 | Upgrade |
Financing Cash Flow | -39.44 | -35.1 | -28.09 | -24.61 | -20.51 | -27.82 | Upgrade |
Foreign Exchange Rate Adjustments | 2.4 | -0.6 | 0.83 | -1.08 | -0.68 | -0.16 | Upgrade |
Net Cash Flow | -61 | 103.52 | 53.73 | 50.88 | 14.9 | 23.4 | Upgrade |
Free Cash Flow | 160.06 | 142.22 | 98.11 | 76.56 | 80.76 | 80.52 | Upgrade |
Free Cash Flow Growth | 36.60% | 44.95% | 28.15% | -5.21% | 0.30% | 9.97% | Upgrade |
Free Cash Flow Margin | 18.32% | 17.21% | 13.94% | 13.54% | 15.99% | 18.92% | Upgrade |
Free Cash Flow Per Share | 5.41 | 4.82 | 3.33 | 2.61 | 2.75 | 2.75 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.12 | 0.09 | Upgrade |
Cash Income Tax Paid | 56.04 | 56.04 | 38.93 | 24.04 | 19.98 | 18 | Upgrade |
Levered Free Cash Flow | 136.58 | 114.39 | 76.24 | 69.78 | 64.28 | 74.15 | Upgrade |
Unlevered Free Cash Flow | 136.58 | 114.39 | 76.24 | 69.78 | 64.28 | 74.17 | Upgrade |
Change in Net Working Capital | -1.97 | 9.83 | 18.76 | 8.65 | 8.66 | -15.08 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.